SPARQL | HTML Microdata document
This HTML5 document contains 24 embedded RDF statements represented using HTML+Microdata notation.
The embedded RDF content will be recognized by any processor of HTML5 Microdata.
Namespace Prefixes
Prefix IRI
n5 http://linked.opendata.cz/resource/mesh/concept/
rdfs http://www.w3.org/2000/01/rdf-schema#
rdf http://www.w3.org/1999/02/22-rdf-syntax-ns#
owl http://www.w3.org/2002/07/owl#
n4 http://linked.opendata.cz/ontology/mesh/
nci http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#
n7 http://linked.opendata.cz/resource/ndfrt/ingredient/
xsdh http://www.w3.org/2001/XMLSchema#
Statements
Subject Item nci:C1074
rdf:type
owl:Class
rdfs:label
Dinoprost Tromethamine
rdfs:subClassOf
nci:C78568
nci:A6
nci:C65413
nci:A8
nci:C63923
nci:P106
Eicosanoid
Pharmacologic Substance
nci:P108
Dinoprost Tromethamine
nci:P175
196515
nci:P207
C0058310
nci:P210
38562-01-5
nci:P319
CT6BBQ5A68
nci:P322
FDA
nci:P329
39277
nci:P330
39277
nci:P350
C20H34O5.C4H11NO3
nci:P366
Dinoprost_Tromethamine
nci:P90
<n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>DINOPROST TROMETHAMINE</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>FDA</n0:term-source><n0:source-code>CT6BBQ5A68</n0:source-code></n0:ComplexTerm>
<n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Dinoprost Tromethamine</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>
<n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Dinoprost tromethamine</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>DTP</n0:term-source><n0:source-code>NSC0196515</n0:source-code></n0:ComplexTerm>
nci:P97
<n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>A synthetic analogue of the naturally occurring prostaglandin F2 alpha. Prostaglandin F2 alpha stimulates myometrial activity, relaxes the cervix, inhibits corpus luteal steroidogenesis, and induces luteolysis by direct action on the corpus luteum. (NCI04)</n0:def-definition><n0:def-source>NCI</n0:def-source></n0:ComplexDefinition>
nci:code
C1074
owl:sameAs
n7:N0000005702
n4:hasConcept
n5:M0056434